FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1875993546> ?p ?o ?g. }

• W1875993546 endingPage "212" @default.
• W1875993546 startingPage "200" @default.
• W1875993546 abstract "Objective. To further characterize time-to-first pain relief, effect size, correlations between various outcome measures and durability of relief for single-tablet naproxen 500 mg/esomeprazole 20 mg (NAP/ESO) given twice daily and celecoxib (CEL) (200 mg) given once daily versus placebo in knee osteoarthritis (OA). Methods. Unpublished data from two double-blind, double-dummy, placebo-controlled trials in which patients aged ≥50 years with knee OA were randomized to NAP/ESO (n = 487), CEL (n = 486) or placebo (n = 246) were pooled (NCT00664560 and NCT00665431). Acute response endpoints: 1) Time to first significant pain response, 2) Western Ontario and McMaster Osteoarthritis Index (WOMAC) pain subscale and 3) American Pain Society Patient Outcome Questionnaire (APS-POQ) scores. Sustainability endpoints: 1) Routine Assessment of Patient Index Data (RAPID3) and 2) WOMAC Stiffness, Pain and Total scores; and Patient Global Assessment (PGA) at 6 and 12 weeks. Effect sizes for all measures were calculated. Rescue pain medication use also was analyzed, as was the correlation of WOMAC to RAPID3. Results. NAP/ESO produced statistically significant decreases in WOMAC Pain on Days 2–7 and at Weeks 6 and 12 (all p < 0.05); most APS-POQ pain assessments with NAP/ESO were significantly improved on Days 2–7 compared with placebo (all p < 0.05). A good or excellent response occurred in a median of 6 days. RAPID3 and WOMAC total/stiffness/function/PGA scores decreased significantly at Weeks 6 and 12 (all p < 0.05). Placebo-adjusted WOMAC pain effect sizes were 0.44, 0.34 and 0.25 at Day 7, week 6 and week 12, respectively. RAPID3 to WOMAC total and WOMAC pain to RAPID3: Pain scores were highly correlated at 6 and 12 weeks (correlation coefficients >0.80). No significant differences in overall responses were found between CEL and NAP/ESO. Conclusion. Naproxen/esomeprazole produced a significant absolute moderate early pain response, which was maintained for 12 weeks. RAPID3 was found to be highly correlated with the typical OA measure (WOMAC) and might be a useful clinical tool for measuring NSAID response. NCT00664560: https://clinicaltrials.gov/ct2/show/NCT00664560, NCT00665431: https://www.clinicaltrials.gov/ct2/show/NCT00665431." @default.
• W1875993546 created "2016-06-24" @default.
• W1875993546 creator A5004250800 @default.
• W1875993546 creator A5017975302 @default.
• W1875993546 creator A5035404908 @default.
• W1875993546 creator A5046574969 @default.
• W1875993546 creator A5056718731 @default.
• W1875993546 date "2015-07-03" @default.
• W1875993546 modified "2023-10-16" @default.
• W1875993546 title "Onset and durability of pain relief in knee osteoarthritis: Pooled results from two placebo trials of naproxen/esomeprazole combination and celecoxib" @default.
• W1875993546 cites W1599185368 @default.
• W1875993546 cites W1964099852 @default.
• W1875993546 cites W1979673901 @default.
• W1875993546 cites W1989740180 @default.
• W1875993546 cites W1990165855 @default.
• W1875993546 cites W1990824360 @default.
• W1875993546 cites W1996390771 @default.
• W1875993546 cites W2000949542 @default.
• W1875993546 cites W2004718890 @default.
• W1875993546 cites W2009487578 @default.
• W1875993546 cites W2015698186 @default.
• W1875993546 cites W2018004536 @default.
• W1875993546 cites W2022672351 @default.
• W1875993546 cites W2035833931 @default.
• W1875993546 cites W2036491373 @default.
• W1875993546 cites W2041998517 @default.
• W1875993546 cites W2054943838 @default.
• W1875993546 cites W2068020172 @default.
• W1875993546 cites W2078909311 @default.
• W1875993546 cites W2080195990 @default.
• W1875993546 cites W2084863173 @default.
• W1875993546 cites W2089414790 @default.
• W1875993546 cites W2095499604 @default.
• W1875993546 cites W2106903173 @default.
• W1875993546 cites W2107178532 @default.
• W1875993546 cites W2108344016 @default.
• W1875993546 cites W2112556629 @default.
• W1875993546 cites W2115805053 @default.
• W1875993546 cites W2122833449 @default.
• W1875993546 cites W2129208878 @default.
• W1875993546 cites W2129281457 @default.
• W1875993546 cites W2129543954 @default.
• W1875993546 cites W2147148117 @default.
• W1875993546 cites W2161736885 @default.
• W1875993546 cites W2164287243 @default.
• W1875993546 cites W2170132723 @default.
• W1875993546 cites W2610860323 @default.
• W1875993546 cites W4211049951 @default.
• W1875993546 doi "https://doi.org/10.1080/00913847.2015.1074852" @default.
• W1875993546 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26313454" @default.
• W1875993546 hasPublicationYear "2015" @default.
• W1875993546 type Work @default.
• W1875993546 sameAs 1875993546 @default.
• W1875993546 citedByCount "12" @default.
• W1875993546 countsByYear W18759935462016 @default.
• W1875993546 countsByYear W18759935462018 @default.
• W1875993546 countsByYear W18759935462020 @default.
• W1875993546 countsByYear W18759935462021 @default.
• W1875993546 countsByYear W18759935462022 @default.
• W1875993546 countsByYear W18759935462023 @default.
• W1875993546 crossrefType "journal-article" @default.
• W1875993546 hasAuthorship W1875993546A5004250800 @default.
• W1875993546 hasAuthorship W1875993546A5017975302 @default.
• W1875993546 hasAuthorship W1875993546A5035404908 @default.
• W1875993546 hasAuthorship W1875993546A5046574969 @default.
• W1875993546 hasAuthorship W1875993546A5056718731 @default.
• W1875993546 hasBestOaLocation W18759935461 @default.
• W1875993546 hasConcept C126322002 @default.
• W1875993546 hasConcept C142724271 @default.
• W1875993546 hasConcept C1862650 @default.
• W1875993546 hasConcept C204787440 @default.
• W1875993546 hasConcept C27081682 @default.
• W1875993546 hasConcept C2776164576 @default.
• W1875993546 hasConcept C2776467144 @default.
• W1875993546 hasConcept C2778115740 @default.
• W1875993546 hasConcept C2779286237 @default.
• W1875993546 hasConcept C71924100 @default.
• W1875993546 hasConceptScore W1875993546C126322002 @default.
• W1875993546 hasConceptScore W1875993546C142724271 @default.
• W1875993546 hasConceptScore W1875993546C1862650 @default.
• W1875993546 hasConceptScore W1875993546C204787440 @default.
• W1875993546 hasConceptScore W1875993546C27081682 @default.
• W1875993546 hasConceptScore W1875993546C2776164576 @default.
• W1875993546 hasConceptScore W1875993546C2776467144 @default.
• W1875993546 hasConceptScore W1875993546C2778115740 @default.
• W1875993546 hasConceptScore W1875993546C2779286237 @default.
• W1875993546 hasConceptScore W1875993546C71924100 @default.
• W1875993546 hasIssue "3" @default.
• W1875993546 hasLocation W18759935461 @default.
• W1875993546 hasLocation W18759935462 @default.
• W1875993546 hasOpenAccess W1875993546 @default.
• W1875993546 hasPrimaryLocation W18759935461 @default.
• W1875993546 hasRelatedWork W1875993546 @default.
• W1875993546 hasRelatedWork W1990986050 @default.
• W1875993546 hasRelatedWork W1991350847 @default.
• W1875993546 hasRelatedWork W2120551915 @default.
• W1875993546 hasRelatedWork W2153862724 @default.
• W1875993546 hasRelatedWork W2607725890 @default.

• next